TY - JOUR
T1 - No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing
AU - Ingerslev, Kasper
AU - Poulsen, Tim Svenstrup
AU - Strube, Mikael Lenz
AU - Skovrider-Ruminski, Wojciech
AU - Schledermann, Doris
AU - Schnack, Tine Henrichsen
AU - Høgdall, Claus
AU - Blaakær, Jan
AU - Høgdall, Estrid
N1 - © 2025 Scandinavian Societies for Pathology, Medical Microbiology and Immunology.
PY - 2025/1
Y1 - 2025/1
N2 - The ovarian oncobiome is subject to increasing scientific focus, but a potential link between bacterial dysbiosis and ovarian carcinogenesis remains controversial. Our primary aim was to characterize the bacterial microbiota in epithelial ovarian cancer samples. Secondarily, we aimed to compare results from the bacterial microbiota in formalin-fixed, paraffin-embedded ovarian tissue samples from 194 patients with epithelial ovarian cancer, fallopian tube tissue samples from 16 patients with serous tubal intraepithelial carcinomas and in benign fallopian tube tissue samples from 25 patients. Bacterial abundance was investigated by means of 16S rDNA Next Generation Sequencing. The 16S rDNA sequencing run produced a very low number of bacterial reads. Only seven samples displayed bacterial reads above 5000. Validation of detected bacterial reads by qPCR was negative and indicative of results being background amplification. Our results indicate no amount of bacterial biomass in the ovarian cancer, benign fallopian tube and in the samples with serous tubal intraepithelial carcinomas. The findings underline the importance of validating results from bacterial microbiota studies with additional technical assays before any conclusion may be drawn.
AB - The ovarian oncobiome is subject to increasing scientific focus, but a potential link between bacterial dysbiosis and ovarian carcinogenesis remains controversial. Our primary aim was to characterize the bacterial microbiota in epithelial ovarian cancer samples. Secondarily, we aimed to compare results from the bacterial microbiota in formalin-fixed, paraffin-embedded ovarian tissue samples from 194 patients with epithelial ovarian cancer, fallopian tube tissue samples from 16 patients with serous tubal intraepithelial carcinomas and in benign fallopian tube tissue samples from 25 patients. Bacterial abundance was investigated by means of 16S rDNA Next Generation Sequencing. The 16S rDNA sequencing run produced a very low number of bacterial reads. Only seven samples displayed bacterial reads above 5000. Validation of detected bacterial reads by qPCR was negative and indicative of results being background amplification. Our results indicate no amount of bacterial biomass in the ovarian cancer, benign fallopian tube and in the samples with serous tubal intraepithelial carcinomas. The findings underline the importance of validating results from bacterial microbiota studies with additional technical assays before any conclusion may be drawn.
KW - Humans
KW - Female
KW - RNA, Ribosomal, 16S/genetics
KW - Ovarian Neoplasms/microbiology
KW - Bacteria/genetics
KW - Middle Aged
KW - DNA, Bacterial/genetics
KW - Microbiota/genetics
KW - High-Throughput Nucleotide Sequencing/methods
KW - Adult
KW - Aged
KW - Fallopian Tube Neoplasms/microbiology
KW - Fallopian Tubes/microbiology
KW - DNA, Ribosomal/genetics
KW - Carcinoma in Situ/microbiology
KW - Sequence Analysis, DNA/methods
KW - Biomass
UR - http://www.scopus.com/inward/record.url?scp=85215511828&partnerID=8YFLogxK
U2 - 10.1111/apm.13509
DO - 10.1111/apm.13509
M3 - Journal article
C2 - 39821934
SN - 0903-4641
VL - 133
JO - APMIS - Journal of Pathology, Microbiology and Immunology
JF - APMIS - Journal of Pathology, Microbiology and Immunology
IS - 1
M1 - e13509
ER -